INSPECS Group plc (AIM:SPEC)
London · Delayed Price · Currency is GBP · Price in GBX 100.00
+4.00 (4.17%)
Sep 18, 2026, 3:01 PM GMT
INSPECS Group Revenue
INSPECS Group had revenue of 99.15M GBP in the half year ending June 30, 2026, a decrease of -1.45%. This brings the company's revenue in the last twelve months to 193.23M, up 1.51% year-over-year. In the year 2025, INSPECS Group had annual revenue of 191.70M, down -0.85%.
Revenue (ttm)
193.23M
Revenue Growth
+1.51%
P/S Ratio
0.54
Revenue / Employee
116.68K
Employees
1,656
Market Cap
104.81M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 191.70M | -1.64M | -0.85% |
| Dec 31, 2024 | 193.35M | -9.95M | -4.89% |
| Dec 31, 2023 | 203.29M | 2.34M | 1.16% |
| Dec 31, 2022 | 200.96M | 18.65M | 10.23% |
| Dec 31, 2021 | 182.30M | 147.62M | 425.66% |
| Dec 31, 2020 | 34.68M | -11.51M | -24.91% |
| Dec 31, 2019 | 46.19M | 1.20M | 2.67% |
| Dec 31, 2018 | 44.98M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 46.25B |
| GSK plc | 33.20B |
| Haleon | 11.15B |
| Smith & Nephew | 4.77B |
| EKF Diagnostics Holdings | 51.35M |
| AOTI, Inc. | 49.44M |
| Diaceutics | 38.44M |
| Venture Life Group | 35.17M |
INSPECS Group News
- 10 days ago - INSPECS Group Quarterly report: H1 2026 - Filings
- 4 months ago - INSPECS Group Annual report: H2 2025 - Filings
- 4 months ago - INSPECS Group Annual report: H2 2025 - Filings
- 9 months ago - Inspecs Group Plc Notes H2 Equity Partners' Decision On Not To Make Offer - Nasdaq